These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4855871)

  • 1. Catalepsy induced by alpha-methyl-p-tyrosine and d-amphetamine: the rôle of catecholamine metabolism.
    Sayers AC; Handley SL
    Psychopharmacologia; 1974 Feb; 34(4):325-34. PubMed ID: 4855871
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of amphetamine metabolism in the alpha-methyl-p-tyrosine-d-amphetamine catalepsy.
    Sayers AC; Handley SL
    Eur J Pharmacol; 1973 Dec; 24(3):306-9. PubMed ID: 4797389
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of some amphetamine analogues on -methyl-p-tyrosine-induced catalepsy in rats.
    Sayers A; Spencer PS
    Br J Pharmacol; 1971 Dec; 43(4):877-80. PubMed ID: 5170286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition.
    Singh A; Naidu PS; Kulkarni SK
    Pharmacology; 2003 Jun; 68(2):81-8. PubMed ID: 12711835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biosynthesis and metabolism of the catecholamines.
    Sandler M; Ruthven CR
    Prog Med Chem; 1969; 6():200-65. PubMed ID: 4898078
    [No Abstract]   [Full Text] [Related]  

  • 6. The importance of monoamine metabolism for the pathology of the extrapyramidal system.
    Birkmayer W
    J Neurovisc Relat; 1969; 31():Suppl 9:297+. PubMed ID: 4319516
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between amphetamine antagonism and depletion of brain catecholamines by alpha-methyl-p-tyrosine in rats.
    Widerlöv E; Lewander T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):125-34. PubMed ID: 703855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
    Cashin CH; Sutton S
    Br J Pharmacol; 1973 Mar; 47(3):658P-659P. PubMed ID: 4738385
    [No Abstract]   [Full Text] [Related]  

  • 9. Occurrence and functional significance of serotonin and catecholamine uptake by astrocytes.
    Kimelberg HK
    Biochem Pharmacol; 1986 Jul; 35(14):2273-81. PubMed ID: 3089228
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of amphetamine on brain catecholamines, brain beta-endorphin, serum prolactin, catechol-O-methyltransferase and monoamine oxidase of various organs in the rat.
    Agarwal DP; Hoo JJ; Tjaden A; Nishigaki I; Beckermann WJ; Pahnke V; Goedde HW
    Arzneimittelforschung; 1985; 35(11):1639-42. PubMed ID: 2936351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of norlaudanosolinecarboxylic acids on enzymes of catecholamine metabolism.
    Coscia CJ; Burke WJ; Galloway MP; Kosloff AH; Lasala JM; McFarlane J; Mitchell JS; O'Toole MM; Roth BL
    J Pharmacol Exp Ther; 1980 Jan; 212(1):91-6. PubMed ID: 6101345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of alpha-methyl-p-tyrosine on neuroleptic-induced catalepsy in rat.
    Gada VP; Nandal NV; Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1983; 27(3):241-4. PubMed ID: 6141998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inhibition of catecholamine synthesis on central catecholamine-containing neurones in the developing albino rat.
    Loizou LA
    Br J Pharmacol; 1971 Jan; 41(1):41-8. PubMed ID: 5547761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic L-DOPA administration of catecholamine metabolism in the rat.
    Lancaster J; Sawyer PR; Shepherd DM; Turnbull MJ
    Br J Pharmacol; 1973 Apr; 47(4):838-42. PubMed ID: 4723802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

  • 16. Exercise hemodynamics and catecholamine metabolism after catechol-O-methyltransferase inhibition with nitecapone.
    Sundberg S; Scheinin M; Ojala-Karlsson P; Kaakkola S; Akkila J; Gordin A
    Clin Pharmacol Ther; 1990 Oct; 48(4):356-64. PubMed ID: 2225697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine metabolism in pargyline treated rats exposed to stress.
    Prasad R; Patel V; Chansouria JP; Udupa KN
    Endocrinol Exp; 1980; 14(2):147-50. PubMed ID: 6104592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen peroxide (H2O2) production by monoamine oxidase in rat tissues using endogenous catecholamines as substrates. A comparison of catalytic monoamine oxidase histochemistry and recently published catechol-O-methyltransferase immunohistochemistry.
    Nakos G; Gossrau R
    Acta Histochem; 1995 Jan; 97(1):121-7. PubMed ID: 7771182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of anticholinergic agents with -methyl-p-tyrosine and (+)-amphetamine.
    Sayers AC
    Br J Pharmacol; 1972 May; 45(1):170P-171P. PubMed ID: 5064932
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.
    Bianchine JR; Sunyapridakul L
    Drugs; 1973; 6(5):364-88. PubMed ID: 4787755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.